Expanding the potential of NAI-107 for treating serious ESKAPE pathogens: synergistic combinations against Gram-negatives and bactericidal activity against non-dividing cells
出版年份 2017 全文链接
标题
Expanding the potential of NAI-107 for treating serious ESKAPE pathogens: synergistic combinations against Gram-negatives and bactericidal activity against non-dividing cells
作者
关键词
-
出版物
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Volume 73, Issue 2, Pages 414-424
出版商
Oxford University Press (OUP)
发表日期
2017-10-03
DOI
10.1093/jac/dkx395
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- The Lantibiotic NAI-107 Efficiently Rescues Drosophila melanogaster from Infection with Methicillin-Resistant Staphylococcus aureus USA300
- (2016) Thomas T. Thomsen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Synergistic combinations of polymyxins
- (2016) Justin R. Lenhard et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Antimicrobial Resistance
- (2016) Hilary D. Marston et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Antibacterial drug discovery in the resistance era
- (2016) Eric D. Brown et al. NATURE
- Daptomycin inhibits cell envelope synthesis by interfering with fluid membrane microdomains
- (2016) Anna Müller et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mechanisms of bacterial persistence during stress and antibiotic exposure
- (2016) Alexander Harms et al. SCIENCE
- Peptidoglycan Recycling in Gram-Positive Bacteria Is Crucial for Survival in Stationary Phase
- (2016) Marina Borisova et al. mBio
- The evolution of antimicrobial peptide resistance in Pseudomonas aeruginosa is shaped by strong epistatic interactions
- (2016) Nicholas Jochumsen et al. Nature Communications
- Family of Class I Lantibiotics from Actinomycetes and Improvement of Their Antibacterial Activities
- (2015) Sonia I. Maffioli et al. ACS Chemical Biology
- Lipopolysaccharide loss produces partial colistin dependence and collateral sensitivity to azithromycin, rifampicin and vancomycin in Acinetobacter baumannii
- (2015) Meritxell García-Quintanilla et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Advancing cell wall inhibitors towards clinical applications
- (2015) Sonia I. Maffioli et al. JOURNAL OF INDUSTRIAL MICROBIOLOGY & BIOTECHNOLOGY
- Brominated Variant of the Lantibiotic NAI-107 with Enhanced Antibacterial Potency
- (2015) João C. S. Cruz et al. JOURNAL OF NATURAL PRODUCTS
- A new antibiotic kills pathogens without detectable resistance
- (2015) Losee L. Ling et al. NATURE
- Permeability Barrier of Gram-Negative Cell Envelopes and Approaches To Bypass It
- (2015) Helen I. Zgurskaya et al. ACS Infectious Diseases
- In VivoPharmacokinetics and Pharmacodynamics of the Lantibiotic NAI-107 in a Neutropenic Murine Thigh Infection Model
- (2014) Alexander J. Lepak et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Activity of Host Antimicrobials against Multidrug-Resistant Acinetobacter baumannii Acquiring Colistin Resistance through Loss of Lipopolysaccharide
- (2014) M. Garcia-Quintanilla et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Colistin/daptomycin: an unconventional antimicrobial combination synergistic in vitro against multidrug-resistant Acinetobacter baumannii
- (2014) Irene Galani et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- The Lantibiotic NAI-107 Binds to Bactoprenol-bound Cell Wall Precursors and Impairs Membrane Functions
- (2014) Daniela Münch et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Characterization of the Congeners in the Lantibiotic NAI-107 Complex
- (2014) Sonia I. Maffioli et al. JOURNAL OF NATURAL PRODUCTS
- Antibiotics in the clinical pipeline in 2013
- (2013) Mark S Butler et al. JOURNAL OF ANTIBIOTICS
- Novel derivatives of polymyxins
- (2013) M. Vaara JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- In VitroActivity of Telavancin in Combination with Colistin versus Gram-Negative Bacterial Pathogens
- (2012) Michael Hornsey et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Ribosomally synthesized and post-translationally modified peptide natural products: overview and recommendations for a universal nomenclature
- (2012) Paul G. Arnison et al. NATURAL PRODUCT REPORTS
- Efficacy of the New Lantibiotic NAI-107 in Experimental Infections Induced by Multidrug-Resistant Gram-Positive Pathogens
- (2011) Daniela Jabés et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In vitro activity of teicoplanin combined with colistin versus multidrug-resistant strains of Acinetobacter baumannii
- (2011) D. W. Wareham et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Potent Synergy and Sustained Bactericidal Activity of a Vancomycin-Colistin Combination versus Multidrug-Resistant Strains of Acinetobacter baumannii
- (2010) N. C. Gordon et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Colistin Resistance in Acinetobacter baumannii Is Mediated by Complete Loss of Lipopolysaccharide Production
- (2010) J. H. Moffatt et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- An oldie but a goodie – cell wall biosynthesis as antibiotic target pathway
- (2009) Tanja Schneider et al. INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY
- Oritavancin Kills Stationary-Phase and Biofilm Staphylococcus aureus Cells In Vitro
- (2008) A. Belley et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A Population‐Based Study of the Incidence and Molecular Epidemiology of Methicillin‐ResistantStaphylococcus aureusDisease in San Francisco, 2004–2005
- (2008) Catherine Liu et al. CLINICAL INFECTIOUS DISEASES
- Federal Funding for the Study of Antimicrobial Resistance in Nosocomial Pathogens: No ESKAPE
- (2008) Louis B. Rice JOURNAL OF INFECTIOUS DISEASES
- Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances
- (2008) Irith Wiegand et al. Nature Protocols
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now